Adjuvant Chemoradiotherapy for Gastric Cancer: Efficacy and Cost-Effectiveness Analysis
Purpose: The benefit of adjuvant chemotherapy (CT) for localized gastric cancer (GC) after D2-gastrectomy has been clearly demonstrated. However, adjuvant chemoradiotherapy (CRT) remains controversial. This study aimed to assess the efficacy and cost-effectiveness of treatment for GC after D2-gastre...
Main Authors: | Mengxi Zhang, Feng Wen, Xiaofeng He, Weihan Zhang, Jiankun Hu, Qiu Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.01357/full |
Similar Items
-
Chemoradiotherapy Is Inferior to Chemotherapy Alone in Adjuvant Setting for Signet Ring Cell Containing Gastric Cancer
by: Yue-Ting Zhu, et al.
Published: (2020-11-01) -
Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis
by: Daniel M. Girardi, et al.
Published: (2018-04-01) -
Current Situation of Postoperative Adjuvant Chemoradiotherapy for Extrahepatic Cholangiocarcinoma
by: YANG Xiao, et al.
Published: (2023-01-01) -
Adjuvant Chemoradiotherapy Versus Adjuvant Chemotherapy for Stage III Gastric or Gastroesophageal Junction Cancer After D2/R0 Resection
by: Jinming Shi, et al.
Published: (2022-07-01) -
Adjuvant chemoradiotherapy in resected gallbladder cancer: A SEER-based study
by: Yong Jiang, et al.
Published: (2023-03-01)